You are viewing: France Vascular Access Device Market analysis
Part of: Vascular Access Device Market (Global)

The France Vascular Access Device Market was valued at $118 Million in 2026 and projected to reach to $155 Million by 2031, representing a compound annual growth rate of 5.6%. France's vascular access device market is positioned for steady growth through 2031, supported by an aging demographic requiring chronic disease management and an established healthcare infrastructure committed to clinical excellence.

France Vascular Access Device Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Vascular Access Device Market Trends and Insights

  • France's healthcare infrastructure and aging population drive demand for reliable vascular access solutions across hospitals, dialysis centers, and outpatient facilities.
  • The market in France reflects steady adoption of advanced catheter technologies and peripherally inserted central catheters (PICCs) as clinical standards improve. The French vascular access device sector benefits from strong regulatory oversight through the European Medicines Agency and national health authorities, ensuring product quality and safety.
  • France's reimbursement policies and integration within the European healthcare system support consistent market expansion through 2031.
  • Healthcare providers in France increasingly prioritize infection prevention and patient comfort, accelerating uptake of antimicrobial and advanced vascular access solutions..

Key Market Statistics

  • CAGR (2026-2031) 5.6% CAGR
  • Market Size, 2026 ~USD 118 Million
  • Forecast, 2031 ~USD 155 Million
  • Country France

France Vascular Access Device Market Overview

Market Valuation Growth :

France's vascular access device market is valued at $118.0 million in 2026 and is projected to reach $155.0 million by 2031, demonstrating consistent market expansion driven by healthcare infrastructure investments.

Aging Population Dynamics :

France's demographic shift toward an aging population increases prevalence of chronic conditions requiring vascular access, particularly in dialysis and long-term care settings across the country.

Healthcare Infrastructure Strength :

France's robust healthcare system with extensive hospital networks, specialized dialysis centers, and outpatient facilities creates sustained demand for advanced vascular access solutions and regular device replacement cycles.

Steady Adoption Trajectory :

The French market reflects measured adoption of innovative vascular access technologies, with healthcare providers prioritizing quality and clinical outcomes in device selection and procurement decisions.

France Vascular Access Device Market Dynamics

  • The 5.6% CAGR reflects France's mature healthcare market with consistent demand from hospitals, dialysis centers, and outpatient facilities.
  • Healthcare providers in France are increasingly adopting advanced vascular access solutions to improve patient outcomes and reduce complications.
  • Government healthcare policies and reimbursement frameworks continue to support investment in quality medical devices, ensuring reliable access to vascular solutions across all care settings..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • France's vascular access device market will grow from $118.0M (2026) to $155.0M (2031) at a 5.6% CAGR.
    • France's aging population and advanced healthcare infrastructure drive steady demand for vascular access solutions.
    • Strong European regulatory frameworks and reimbursement policies support market stability and growth in France.
    • French healthcare providers increasingly adopt antimicrobial and advanced catheter technologies to reduce infection rates.

    Vascular Access Device Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment SUBCUTANEOUS (Route Of Insertion)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.7% from 2026 to 2031
    Largest Segment INTRAVENOUS (Route Of Insertion)
    Market Size Base Year (Billions) ~USD 6.29 (2026)
    Revenue Forecast (Billions) ~USD 8.7 (2031)
    Segments Covered Type, Route Of Insertion, Application, End User

    France Vascular Access Device Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Type

    • Accessories
    • Butterfly/Winged Steel Needles
    • Central Venous Access Devices
    • Chemotherapy
    • Implantable Conventional Ports
    • Implantable Ports
    • Implantable Power Injectable Ports
    • Integrated/Accelerated Midline Catheters
    • Intraosseous Vascular Access Devices
    • Midline Catheters
    • Mst Max Barrier Midline Catheters
    • Non-Tunneled Catheters
    • Other Drug Administration Applications
    • Peripheral Arterial Access Devices
    • Peripheral Intravenous Catheters
    • Peripheral Vascular Access Devices
    • Peripheral Venous Access Devices
    • Peripherally Inserted Central Catheters
    • Private
    • Public
    • Tunneled Catheters

    By Route Of Insertion

    • Intraosseous
    • Intravenous
    • Subcutaneous

    By Application

    • Blood Transfusion
    • Diagnostics & Testing
    • Drug Administration
    • Fluid & Nutrition Administration

    By End User

    • Ambulatory Care Centers
    • Clinics
    • Hospitals
    • Other End Users

    FRANCE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY CARE CENTERS4244.947.650.553.857.461.565.96.7
    CLINICS28.930.732.434.236.338.641.243.96.3
    HOSPITALS100.5106.4111.6117.2123.7130.9138.7147.35.7
    OTHER END USERS21.222.523.72526.528.230326.2
    TOTAL192.5204.5215.4227240.3255.1271.4289.26.1

    Target Audience

    • Medical Device Manufacturers : Manufacturers need France-specific market data to develop localized product strategies, identify growth opportunities in dialysis and hospital segments, and optimize market penetration in this mature European healthcare market.
    • Healthcare Providers & Hospital Networks : French hospitals and dialysis centers require market intelligence to benchmark procurement practices, evaluate supplier performance, and make evidence-based decisions on vascular access device investments.
    • Distributors & Suppliers : Medical device distributors operating in France need market forecasts and growth trends to optimize inventory management, negotiate supplier contracts, and identify emerging opportunities in vascular access solutions.
    • Investment & Private Equity Firms : Investors evaluating opportunities in French healthcare need detailed market analysis, growth projections, and competitive landscape data to assess investment viability and portfolio company performance.
    • Healthcare Consultants & Analysts : Consultants advising French healthcare organizations require country-specific market data, demographic trends, and clinical insights to develop strategic recommendations and support decision-making processes.

    Key Companies in the France Vascular Access Device Market

    CompanyHQOwnershipStrongest segments
    PENUMBRA, INC.United StatesPublic CompanyNeurovascular thrombectomy (Penumbra System, RED, JET, ACE, ENGINE, 3D Revascularization Device),Peripheral thrombectomy (Indigo, Lightning Flash, Lightning Bolt 7, CAT RX),Neuro and peripheral embolization (Ruby platforms, POD, coils, LANTERN, Packing Coil),
    SANOFIFrancePublic CompanyPediatric and Combination Vaccines (including hexavalent),Other Vaccines (RSV, travel, rabies, yellow fever, typhoid, hepatitis A),Immunology & Inflammation Therapies,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, IV and vascular access, sharps, basic disposables),Connected Care (infusion, medication management, pharmacy automation, informatics, hemodynamic monitoring),BioPharma Systems (prefillable drug delivery systems and related services),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular access and emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),Interventional cardiology and peripheral (GuideLiner, Turnpike, TrapLiner, MANTA, DCBs, stents, balloons),
    ICU MEDICAL INC.United StatesPublic CompanyIV solutions and diluents,Infusion pumps and hardware,Vascular access and needlefree connectors,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular – Peripheral Intervention (angiography, drainage, delivery, embolotherapy),Cardiovascular – Cardiac Intervention (access, EP/CRM, fluid management, hemodynamic, hemostasis),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),
    NIPRO CORPORATIONJapanPublic CompanyRenal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion (syringes, catheters, IV sets),Glass pharma packaging and components,
    ANGIODYNAMICSUnited StatesPublic CompanyMed Tech (Auryon, AlphaVac, AngioVac, NanoKnife, Solero, VenaCure EVLT),Med Device (peripheral catheters, guidewires, ports, drainage, micropuncture kits),
    AMECATHEgyptPrivate CompanyDialysis catheters,Central venous and midline catheters,Urology catheters,

    PENUMBRA, INC.

    PENUMBRA, INC. is a United States-based public company founded in 2004 with 4700 employees.

    SANOFI

    SANOFI is a French public company founded in 1994 with 74846 employees.

    BECTON, DICKINSON AND COMPANY

    BECTON, DICKINSON AND COMPANY is a United States-based public company founded in 1897 with 72000 employees.

    TERUMO CORPORATION

    TERUMO CORPORATION is a Japanese public company founded in 1921 with 30591 employees.

    TELEFLEX INCORPORATED

    TELEFLEX INCORPORATED is a United States-based public company founded in 1943 with 15500 employees.

    ICU MEDICAL INC.

    ICU MEDICAL INC. is a United States-based public company founded in 1984 with 13000 employees.

    MERIT MEDICAL SYSTEMS

    MERIT MEDICAL SYSTEMS is a United States-based public company founded in 1987 with 7500 employees.

    NIPRO CORPORATION

    NIPRO CORPORATION is a Japanese public company founded in 1954.

    ANGIODYNAMICS

    ANGIODYNAMICS is a United States-based public company founded in 1988 with 632 employees.

    AMECATH

    AMECATH is an Egypt-based private company founded in 1991.

    Reasons to Buy this Report

    • Country-Specific Market Sizing : Obtain precise valuation data for France's vascular access device market with verified 2026-2031 projections, enabling accurate budget allocation and revenue forecasting for French healthcare operations.
    • Demographic & Clinical Insights : Understand France's aging population dynamics and chronic disease prevalence driving vascular access demand across hospitals, dialysis centers, and outpatient facilities specific to the French healthcare landscape.
    • Competitive Positioning Strategy : Benchmark your market position against competitors in France with localized growth trends, adoption patterns, and healthcare provider preferences to optimize market entry or expansion strategies.
    • Reimbursement & Regulatory Context : Gain insights into France's healthcare reimbursement frameworks and regulatory environment that influence vascular access device procurement, pricing, and adoption across French medical institutions.
    • Investment & Partnership Decisions : Make informed decisions on French market investments, partnerships, and distribution strategies based on comprehensive market analysis, growth forecasts, and healthcare infrastructure assessments.

    Frequently asked questions

    What is the current size of France's vascular access device market?

    France's vascular access device market is valued at $118.0 million in 2026.

    What is the projected market size for France by 2031?

    France's vascular access device market is projected to reach $155.0 million by 2031.

    What is the growth rate for France's vascular access device market?

    France's vascular access device market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2031.

    What factors drive growth in France's vascular access device market?

    Key drivers include France's aging population, advanced healthcare infrastructure, strong regulatory standards, favorable reimbursement policies, and increasing adoption of antimicrobial and advanced catheter technologies.

    How does France's market compare to the global vascular access device market?

    France's 5.6% CAGR is slightly lower than the global CAGR of 6.7%, reflecting France's mature healthcare system and stable market conditions.

    RESEARCH METHODOLOGY

    Secondary research was conducted to gather information for this technical, market-oriented, and commercial study of the global vascular access device (VAD) market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up, were used to estimate the total market size. After that, market breakup and data triangulation procedures were used to estimate the size of the segments and subsegments of the VAD market.

    Secondary Research

    In the secondary research process, various secondary sources were consulted to identify and collect information for the study. These sources included annual reports, press releases, and investor presentations of device manufacturers; regulatory filings and clearance databases; clinical literature and peer-reviewed journals; healthcare and infection-control association publications; certified publications; and white papers. Secondary research was primarily used to obtain key information on the industry's supply chain, the total pool of key players, market classification and segmentation according to industry trends down to the most granular level, regional markets, and key developments from both market- and technology-oriented perspectives. All of this information was further validated by primary sources.

    Primary Research

    In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report: marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the vascular access device market. Primary sources on the demand side include directors and presidents of hospitals & cardiac centers, as well as scientists/researchers from academic & research institutes. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends and dynamics.

    In the market engineering process, top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was conducted throughout the market engineering process to present key information and insights throughout the report.

    After the complete market engineering process—including calculations for market statistics, market breakups, market size estimates, market forecasts, and data triangulation—extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also used to identify segmentation types, industry trends, the competitive landscape among VAD market players, and key market dynamics, including drivers, restraints, opportunities, challenges, and key strategies.

    Vascular Access Device Market 
 Size, and Share

    Note 2: Tier 1 companies – revenue higher than USD 10 billion; Tier 2 companies – revenue between USD 1 and 10 billion; Tier 3 companies – revenue between USD 500 million and USD 1 billion.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Top-down and bottom-up approaches were used to estimate and validate the size of the VAD market and the sizes of various dependent subsegments within the overall market. The research methodology used to estimate market size included identifying key market players through secondary research and determining their market shares in each region through both primary and secondary research. This entire procedure included the study of the annual and financial reports of the top market players, and extensive interviews were conducted with key industry leaders, such as CEOs, VPs, directors, and marketing executives, to gain key insights.

    All percentage splits and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data is consolidated and combined with detailed input and analysis from MarketsandMarkets.

    Vascular Access Device Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size using the market size estimation processes explained above, the market was segmented into several segments and subsegments. Data triangulation and market breakup procedures were employed, where applicable, to complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

    Market Definition

    A vascular access device (VAD) is a medical device used to gain access to a patient's bloodstream for the administration of drugs, fluids, blood products, and nutrition, as well as for blood sampling and diagnostic procedures. VADs include peripheral devices (such as peripheral intravenous catheters, midline catheters, and arterial catheters), central devices (such as peripherally inserted central catheters, centrally and non-tunneled/tunneled central venous catheters, and implantable ports), and intraosseous access systems, along with related accessories. These devices incorporate features such as safety-engineered designs, antimicrobial and antithrombogenic coatings, and compatibility with ultrasound-guided insertion to ensure safe, reliable, and repeatable vascular access across hospital, ambulatory, and home-care settings.

    Key Stakeholders

    • Vascular access device manufacturers and suppliers
    • Hospitals, clinics, and ambulatory care centers
    • Clinicians (interventional radiologists, vascular access nurses, anesthesiologists, and intensivists)
    • Hospital procurement teams and group purchasing organizations (GPOs)
    • Infection-prevention and patient-safety professionals
    • Distributors, dealers, and contract manufacturers
    • Regulatory authorities and healthcare standards organizations
    • Research institutes and academic medical centers
    • Investors and technology partners

    Report Objectives

    • To describe and forecast the global vascular access device market by type, route of insertion, application, end user, and region from 2026 to 2031, and to analyze the various macroeconomic and microeconomic factors that affect market growth.
    • To forecast the market size of five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.
    • To analyze the subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market.
    • To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing market growth.
    • To analyze opportunities in the market for stakeholders and to provide details of the competitive landscape of major players.
    • To profile key market players and comprehensively analyze their business overviews, regional presence, product offerings, business strategies, and key financials, and to illustrate the competitive landscape of the market.
    • To analyze competitive developments such as mergers & acquisitions, product launches, partnerships and collaborations, and research & development (R&D) activities in the market.

    Available customizations:

    With the provided market data, MarketsandMarkets offers customizations tailored to company-specific needs. The following customization options are available for the report:

    Geographic Analysis

    • Further breakup of the Rest of Asia Pacific market, by country
    • Further breakup of the Rest of Europe market, by country
    • Further breakup of the Rest of Latin America market, by country
    • Further breakup of the Middle East & African market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

     

    Get the Full Vascular Access Device Market Report

    Full forecast, segment splits, and company analysis for all Vascular Access Device Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status